<DOC>
	<DOCNO>NCT00330902</DOCNO>
	<brief_summary>In area seasonal malaria transmission , treatment carrier malaria parasite , whose parasitaemia persist low level throughout dry season , could useful strategy malaria control area short transmission season . We randomize trial compare two regimen clearance low level parasitaemia dry season .</brief_summary>
	<brief_title>Randomized Trial Two Antimalarial Treatments Clearing Low Density P.Falciparum Parasitaemia Sudan</brief_title>
	<detailed_description>104 individual low density Plasmodium falciparum infection detect polymerase chain reaction ( PCR ) randomize receive sulfadoxine-pyrimethamine three daily dos artesunate ( SP+AS ) SP+AS dose primaquine ( SP+AS+PQ ) , follow 14 day transmission-free season Eastern Sudan . Subjects visit day 3 , 7 14 start treatment record adverse event detect P.falciparum use PCR . PCR positive sample test gametocyte use RT-PCR . Packed cell volume measure day 7 14 .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Parasitemia</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<criteria>infection P.falciparum detect PCR pregnancy severe anaemia fever sign illness history allergy sulfa drug presence specie Plasmodium detect microscopy</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>malaria</keyword>
	<keyword>subpatent parasitaemia</keyword>
	<keyword>dry season</keyword>
	<keyword>primaquine</keyword>
	<keyword>Plasmodium falciparum infection detect PCR</keyword>
</DOC>